Researchers working across several countries have introduced an innovative method that combines artificial intelligence with three-dimensional imaging to improve the detection of abnormal cervical cells. The research includes contributions from scientists in Portugal, where experts from the Faculty of Medicine of the University of Porto participated in the development of the technology.
The approach focuses on improving the analysis of cervical cell samples used in screening programmes for Cervical Cancer. According to the research, the system employs artificial intelligence algorithms to examine cellular characteristics and classify them as either normal or potentially abnormal, supporting clinicians in identifying suspicious changes at an earlier stage.
A technological shift in cervical screening
Traditional screening methods, including the widely used Pap Smear Test, typically rely on trained professionals examining samples under a microscope. While effective, this process may involve a degree of interpretation variability between observers. Researchers involved in the new study highlight that automated tools could help reduce subjectivity and enhance diagnostic consistency.
The new system works by scanning cellular samples and generating a three-dimensional reconstruction of the cells. This allows specialists to visualise structural details more clearly than in conventional two-dimensional microscopy. Artificial intelligence then analyses these images, identifying patterns and grouping similar cellular profiles to detect abnormalities that may indicate early disease.
International collaboration in cancer diagnostics
The project involved a multidisciplinary collaboration of scientists, healthcare institutions and technology developers from several countries, including Japan, China, United States and Portugal. Findings from the research were published in the scientific journal Nature, highlighting growing global interest in the use of advanced digital tools in medical diagnostics.
Experts involved in the study emphasise that the integration of artificial intelligence into cytological analysis could accelerate screening procedures and improve the identification of early lesions. Early detection is widely recognised as a critical factor in reducing mortality from cervical cancer.
The role of HPV in cervical cancer
Most cases of cervical cancer are linked to infection with Human Papillomavirus (HPV), a virus commonly transmitted through sexual contact. According to international public health data, HPV-related cancers represent a significant proportion of cancers affecting women worldwide.
Healthcare specialists note that early cellular changes caused by the virus may develop gradually over time, making screening programmes essential for detecting abnormalities before they progress to invasive cancer.
Potential benefits for laboratories and clinicians
The automated platform developed in this research aims to assist pathology laboratories by providing a visual mapping system that categorises cells according to their characteristics. Such tools could support pathologists in identifying abnormal patterns more efficiently while reducing the risk of human error during manual evaluation.
Researchers involved in the project suggest that, if implemented widely, the technology could enhance screening programmes in different healthcare systems. Improving diagnostic precision and speed may help clinicians begin treatment earlier, which is a key factor in improving patient outcomes.
Early warning signs and global relevance
Although screening remains the most effective preventive strategy, healthcare organisations also emphasise the importance of recognising potential warning signs of cervical cancer. These may include abnormal vaginal bleeding, changes in vaginal discharge, pelvic pain or discomfort during sexual intercourse.
As research into artificial intelligence continues to expand within healthcare, specialists believe that digital innovations may play an increasingly important role in strengthening cancer detection and prevention strategies worldwide. The development of advanced diagnostic technologies in Portugal and other countries reflects a broader effort to modernise screening methods and improve women’s health outcomes globally.